The Drug Enforcement Administration this week proposed changing rules that govern the amount of prescription opioids that drug manufacturers can produce each year. The changes could sharply reduce the annual production of opioids, Reuters reports.
The Food and Drug Administration will host a public meeting April 17 on patient-focused drug development for opioid use disorder, in collaboration with the National Institute on Drug Abuse.
The acting chief of the Drug Enforcement Administration told the House Energy and Committee this week the agency is doing a better job of tracking the flow of opioid painkillers from manufacturers to pharmacies, The Washington Post reports.
A new study finds there are no significant differences between young adults who misuse prescription opioids and those who inject heroin, except for the amount of time they have used drugs.
Deaths from overdoses of prescription sedatives known as benzodiazepines—including Xanax and Valium—are on the rise, according to a report in the New England Journal of Medicine.
A new Justice Department task force will examine the role of drug manufacturers and distributors in the opioid crisis, Attorney General Jeff Sessions said this week.
Purdue Pharma, the maker of OxyContin, said it will no longer market the drug to doctors. The announcement comes in response to lawsuits that blame the company for helping to trigger the opioid crisis, CBS News reports.
A new study finds that people who live with someone with a prescription for opioid painkillers are more likely to get their own prescription for opioids.
President Trump’s opioid commission last week focused on health insurance companies’ role in contributing to the addiction crisis. The commission is scheduled to deliver its final report on November 1.
Representative Tom Marino of Pennsylvania announced this week he is withdrawing his name from consideration as head of the White House Office of National Drug Control Policy. His decision comes in the wake of a Washington Post and 60 Minutes joint report that concluded legislation Marino sponsored hampered efforts by the Drug Enforcement Administration to fight the opioid epidemic.
Two Democratic senators have introduced legislation that would repeal a law they say hampers efforts by the Drug Enforcement Administration to fight the opioid epidemic.
Medicare has not put significant restrictions in place for opioid prescriptions, despite recent government guidelines that recommend such limits, according to a new study.
Hospital treatment rates for heroin rose more than 31 percent between 2008 and 2014, while treatment rates for prescription opioids have declined, according to a new study.
Health insurer Cigna announced this week it will stop covering the prescription opioid OxyContin in an effort to reduce inappropriate use of the drug. Instead it will cover an equivalent drug less vulnerable to being misused.
The Food and Drug Administration announced it will require makers of fast-acting opioids to fund voluntary training for healthcare professionals who prescribe the drugs, according to Reuters.
CVS announced it will set limits on opioid prescriptions and add in-store disposal units for consumers so they can drop off unwanted and unused medications.
Drug company and government officials announced new efforts designed to fight opioid addiction during a meeting this week of the President's Commission on Combating Drug Addiction and the Opioid Crisis.
President Trump this week promised to win the fight against the opioid epidemic, but declined to act on a recommendation to declare a national emergency. He offered no new recommendations, Reuters reports.
This website uses cookies. We use cookies and similar technologies to give
you the best experience. By using this website, you accept our Privacy Policy and Terms of Use.
Get Support
